K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is headquartered in Minato, Japan.
Frequently asked questions
What sector does K Pharma (4896) operate in?
K Pharma belongs to the Other sector and operates in the Biotechnology industry.
What is K Pharma (4896) current stock price?
As of the latest data, K Pharma stock price is ¥771, with a previous close of ¥771.
What is K Pharma (4896) current market capitalization?
K Pharma market cap is approximately 8.96 billion.
What is K Pharma (4896) Earnings Per Share (EPS)?
The trailing EPS is -¥86.
What is K Pharma (4896) EBITDA?
K Pharma EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -242.25 million.
Does K Pharma (4896) pay dividends?
No. K Pharma does not pay a dividend.
What is K Pharma (4896) beta (volatility) score?
K Pharma has a beta of 0.422, indicating lower volatility than the overall market.